Cantargia Ab Stock Fundamentals
| CANTA Stock | SEK 1.58 0.02 1.28% |
Cantargia AB fundamentals help investors to digest information that contributes to Cantargia's financial success or failures. It also enables traders to predict the movement of Cantargia Stock. The fundamental analysis module provides a way to measure Cantargia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cantargia stock.
Cantargia |
Cantargia AB Company Shares Outstanding Analysis
Cantargia's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cantargia Shares Outstanding | 166.99 M |
Most of Cantargia's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cantargia AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cantargia AB has 166.99 M of shares currently outstending. This is 7.5% lower than that of the Healthcare sector and 56.28% higher than that of the Biotechnology industry. The shares outstanding for all Sweden stocks is 70.8% higher than that of the company.
Cantargia AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cantargia's current stock value. Our valuation model uses many indicators to compare Cantargia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cantargia competition to find correlations between indicators driving Cantargia's intrinsic value. More Info.Cantargia AB is rated third in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cantargia's earnings, one of the primary drivers of an investment's value.Cantargia Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cantargia's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cantargia could also be used in its relative valuation, which is a method of valuing Cantargia by comparing valuation metrics of similar companies.Cantargia is currently under evaluation in shares outstanding category among its peers.
Cantargia Fundamentals
| Return On Equity | -0.69 | |||
| Return On Asset | -0.4 | |||
| Current Valuation | 34.5 M | |||
| Shares Outstanding | 166.99 M | |||
| Shares Owned By Insiders | 9.10 % | |||
| Shares Owned By Institutions | 33.60 % | |||
| Price To Earning | 2.12 X | |||
| Price To Book | 1.11 X | |||
| EBITDA | (363.06 M) | |||
| Net Income | (370.27 M) | |||
| Cash And Equivalents | 842.44 M | |||
| Cash Per Share | 8.41 X | |||
| Current Ratio | 16.19 X | |||
| Book Value Per Share | 2.87 X | |||
| Cash Flow From Operations | (346.44 M) | |||
| Earnings Per Share | (4.11) X | |||
| Target Price | 20.33 | |||
| Number Of Employees | 27 | |||
| Beta | 1.67 | |||
| Market Capitalization | 915.45 M | |||
| Total Asset | 600.24 M | |||
| Retained Earnings | (70 M) | |||
| Working Capital | 21 M | |||
| Current Asset | 30 M | |||
| Current Liabilities | 9 M | |||
| Net Asset | 600.24 M |
About Cantargia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cantargia AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cantargia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cantargia AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Cantargia AB , a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. Cantargia AB was founded in 2010 and is based in Lund, Sweden. Cantargia operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cantargia Stock Analysis
When running Cantargia's price analysis, check to measure Cantargia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cantargia is operating at the current time. Most of Cantargia's value examination focuses on studying past and present price action to predict the probability of Cantargia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cantargia's price. Additionally, you may evaluate how the addition of Cantargia to your portfolios can decrease your overall portfolio volatility.